| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 659 |
| 1 | LEFLUNOMIDE | 637 |
| 2 | ADALIMUMAB | 630 |
| 3 | METHOTREXATE SODIUM | 629 |
| 4 | TOCILIZUMAB | 626 |
| 5 | DICLOFENAC SODIUM | 615 |
| 6 | DICLOFENAC | 605 |
| 7 | ETANERCEPT | 604 |
| 8 | METHOTREXATE | 599 |
| 9 | ALENDRONATE SODIUM | 597 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN OINTMENT | 286 | 0.1166 |
| 1 | HYDROCORTISONE BUTYRATE | 175 | 0.0886 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 489 | 0.0564 |
| 3 | DICLOFENAC POTASSIUM | 489 | 0.0442 |
| 4 | CAFFEINE CITRATE | 102 | 0.0437 |
| 5 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 28 | 0.0426 |
| 6 | GOLIMUMAB | 520 | 0.0413 |
| 7 | TRIPROLIDINE HYDROCHLORIDE | 8 | 0.0410 |
| 8 | CORTISONE ACETATE | 480 | 0.0384 |
| 9 | HYDROCORTISONE SODIUM SUCCINATE | 153 | 0.0383 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 725 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 676 |
| 2 | Corticosteroid [EPC] | 675 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 668 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 666 |
| 5 | Antirheumatic Agent [EPC] | 637 |
| 6 | Vitamin C [EPC] | 630 |
| 7 | Vitamin B12 [EPC] | 602 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 599 |
| 9 | Interleukin-17A Antagonist [EPC] | 594 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 40 | 0.0581 |
| 1 | Endoglycosidase [EPC] | 87 | 0.0470 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 153 | 0.0175 |
| 3 | Interleukin-17A Antagonist [EPC] | 594 | 0.0159 |
| 4 | Provitamin D2 Compound [EPC] | 433 | 0.0146 |
| 5 | Tetracycline-class Drug [EPC] | 470 | 0.0066 |
| 6 | Antirheumatic Agent [EPC] | 637 | 0.0060 |
| 7 | Aminosalicylate [EPC] | 585 | 0.0058 |
| 8 | Methylxanthine [EPC] | 296 | 0.0051 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 666 | 0.0048 |